Catalyst Wire Dossier Catalyst Wire Dossier

Quadrivalent live intranasal influenza vaccine (QLAIV)

Quadrivalent live attenuated influenza vaccine
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Quadrivalent live intranasal influenza vaccine (QLAIV), covering 2017-10-16 to 2017-10-16. Get the full timeline:

Most recent: Clinical Trial Update: Shedding, Immunogenicity and Safety of Quadrivalent Live Intranasal Influenza Vaccine (QLAIV) in HIV-infected Children and Young Adults [Phase 2]

See pricing